inhaled corticosteroids
Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review
... There is wide variability in the response to inhaled corticosteroids (ICS) in asthma. While some of this heterogeneity of response is due to adherence and environmental causes, genetic variation also ...
25
A study on HbA1c profile in children with asthma using inhaled corticosteroids
... Background: Inhaled corticosteroids (ICS) are the mainstay of treatment for persistent bronchial asthma in children. Even though ICS is comparatively safe, few systemic toxicities have been reported. We ...
5
Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: A population-based study
... systemic corticosteroids were not fully sup- portive of their protective effect in ARDS patients ...contrary, inhaled corticosteroids (ICS) with similar anti-inflammatory properties and direct ...
8
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
... 34. Rivero-Calle I, Pardo-Seco J, Aldaz P, Vargas DA, Mascaros E, Redondo E, Diaz-Maroto JL, Linares-Rufo M, Fierro-Alacio MJ, Gil A, et al. Incidence and risk factor prevalence of community-acquired pneumonia in adults ...
8
Questionnaire about the risk of growth suppression of inhaled corticosteroids
... background Inhaled corticosteroids are associated with a risk of growth suppression in children. The aim of the present study was to assess what children with asthma, lay people and paediatricians feel ...
6
Stepping down the dose of inhaled corticosteroids for adults with asthma
... 2016). Inhaled corticosteroids, which effectively relieve symptoms and prevent asthma exacerbations (Adams 2005; Adams 2008), are preferable to treatment by the oral route, as they lead to lower systemic ...
64
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
... from inhaled corticosteroid long-acting beta-agonist combination inhalers on the frequency of exacerba- tions, (rate ratio [RR], ...the inhaled corticosteroids currently available (fluticasone and ...
7
Adherence and Nonadherence to Inhaled Corticosteroids in Asthma Patients Factors and Consequences.
... Objectives:Asthma is one of the commonest chronic illnesses worldwide. Inhaled corticosteroids (ICS) are critical components in this disease therapy. Incompliance to prescribed treatment is a major factor ...
7
<p>Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non-randomized Studies</p>
... Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non- randomized Studies.. This article was published[r] ...
9
Inhaled Corticosteroids and Asthma Control in Children: Assessing Impairment and Risk
... man EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch ...
16
Inhaled Corticosteroids and Respiratory Infections in Children With Asthma: A Meta-analysis
... and inhaled corticosteroids); checking the references of retrieved articles including systematic reviews to find additional relevant trials; searching ...
17
The dose of inhaled corticosteroids in patients with COPD: when less is better
... Treatment of patients with COPD in daily practice con- tinues to pose challenges for physicians to achieve the maxi- mum benefit of non-pharmacological measures (eg, smoking cessation and rehabilitation) and ...
9
Toward effective prescription of inhaled corticosteroids in chronic airway disease
... Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.[r] ...
6
Inhaled corticosteroids in COPD: Personalising the therapeutic choice
... recently demonstrated that the combination of ICS/LABA reduced exacerbation rates to a greater degree than either component alone. It has been proposed that the mechanism of this synergistic effect is the LABA enhancing ...
7
Inhaled corticosteroids and the risk of pneumonia in people with asthma
... of inhaled corticosteroid and risk of pneumonia or lower respiratory tract infection (p-trend <0∙001), such that after adjusting for confounders people receiving the highest strength of inhaled ...
18
Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort
... of inhaled corticosteroids (ICS) in the current Global Initiative for Chronic Obstructive Lung Disease (GOLD) group A and B patients with chronic obstructive pulmonary disease (COPD) is not uncommon in ...
6
Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
... Methods: In this nested case–control study using data from the Dutch PHARMO Record Linkage System, children aged 5–12 years who had an asthma exacerbation needing oral corticosteroids or hospital admission were ...
8
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
... In analyses of data from the FORWARD and Dransfield studies, patients treated with ICS/LABA demonstrated similar COPD exacerbation rates and lung function across all base[r] ...
8
Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
... Multivariately, the strongest predictors for suboptimal use of ICS were an increase in FEV 1 /VC ratio and $1 hospital admissions in the year prior to inclusion in this study. An important predictor for underuse of ICS ...
10
Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
... fact, inhaled fluticasone propi- onate or budesonide used for the treatment of COPD is absorbed through the gastrointestinal tract and first-pass metabolism of the liver, thus a complete absence of sys- temic ...
8